Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

US lawmakers are pushing the Food and Drug Administration to control the increasing market of fake weight-loss medications.

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Scientists have revealed a potential 'neurobiotic' sixth sense derived from direct communication between microorganisms and ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Novo Nordisk A/S (NYSE: NVO) has reported that it retains about sixty percent of the list price of Ozempic and Wegovy, its ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...